Market Overview: The south korea cancer biomarkers market is experiencing rapid growth, driven by the increasing prevalence of different types of cancer across the country, technological advancements in genomics and proteomics, and strong government support for precision diagnostics and oncology research. According to IMARC Group's latest research publication, "South Korea Cancer Biomarkers Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034," the South Korea cancer biomarkers market size reached USD 596.52 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,532.13 Million by 2034, exhibiting a growth rate (CAGR) of 11.05% during 2026-2034. This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources.…